In context
Dihexa appears in experimental cell-differentiation research. One original study used it as part of a small-molecule combination for producing liver-like cells from human pluripotent stem cells. [1–2]
At a glance
- Type
- Peptide / related experimental research
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- This is a laboratory cell-generation experiment, not a trial of memory or dementia treatment. A separate frequently cited cognitive-mechanism paper is retracted and is not used as efficacy evidence here.
How to interpret this evidence
This is a laboratory cell-generation experiment, not a trial of memory or dementia treatment. A separate frequently cited cognitive-mechanism paper is retracted and is not used as efficacy evidence here. [1]
Retracted evidence
The 2014 article on procognitive and synaptogenic effects is marked as retracted in PubMed. It is listed here solely to identify the retraction, not to support a benefit claim. [2]
Safety and clinical context
The evidence described here does not establish safety for unsupervised use. Product identity, route, formulation, interactions and long-term effects cannot be inferred from a study category.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.
- Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy. pubmed.ncbi.nlm.nih.gov
- Retracted publication — not efficacy evidence (PMID 25187433) pubmed.ncbi.nlm.nih.gov